Does semi-quantitative analysis of FDG-PET have any additional value in the diagnosis of mesial temporal sclerosis?;Qual o valor da analise semi-quantitativa dos exames de fdg-pet no diagnostico da esclerose mesial temporal?

Arquivos de Neuro-Psiquiatria

Volumn 59, Issue 4, 2001, Pages 871-874

  Duarte, Paulo S ^a,b   Zhuang, Hongming ^a   Couturier, Olivier ^a   Alavi, Abass ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE   (Brazil)

Author keywords

Epilepsy.; FDG; Mesial temporal sclerosis; PET

Indexed keywords

FLUORODEOXYGLUCOSE; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LOBECTOMY; MALE; POSITRON EMISSION TOMOGRAPHY; SCLEROSIS; TEMPORAL LOBE; ADOLESCENT; BRAIN; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLISM; PATHOLOGY; RETROSPECTIVE STUDY; SCINTISCANNING; TEMPORAL LOBE EPILEPSY;

ADOLESCENT; ADULT; BRAIN; COMPARATIVE STUDY; ENGLISH ABSTRACT; EPILEPSY, TEMPORAL LOBE; FEMALE; FLUDEOXYGLUCOSE F 18; HUMAN; MALE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SUPPORT, U.S. GOV'T, P.H.S.; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035209919     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2001000600007     Document Type: Article

References (11)

1. Falconer MA, Taylor DC. Surgical treatment of drug-resistant epilepsy due to mesial temporal sclerosis: etiology and significance. Arch Neurol 1968;19:353-361.
2. Spencer SS. The relative contributions of MRI, SPECT, and PET imaging in epilepsy. Epilepsia 1994;35(Suppl 6):S72-S89.
3. Engel J Jr., Brown WJ, Kuhl DE, Phelps ME, Mazziotta JC, Crandall PH. Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann Neurol 1982;12:518-528.
4. Mazziotta JC, Engel J Jr. The use and impact of positron computed tomography scanning in epilepsy. Epilepsia 1984;25(Suppl 2):S86-104.
5. Sackellares JC, Siegel GJ, Abou-Khalil BW, et al. Hutchins GD. Differences between lateral and mesial temporal metabolism interictally in epilepsy of mesial temporal origin. Neurology 1990;40:1420-1426.
6. Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med 1995;36:1836-1839.
7. DiChiro G, Brooks RA. PET quantitation: blessing and curse [editorial] [published erratum appears in J Nucl Med 1989;30:129]. J Nucl Med 1988;29:1603-1604.
8. Karp JS, Muehllehner G. Standards for performance measurements of PET scanners: evaluation with the UGM PENN-PET 240H scanner. Med Progr Technol 1991;17:173-187.
9. Karp JS, Freifelder R, Geagan MJ, et al. Three-dimensional imaging characteristics of the HEAD PENN-PET scanner. J Nucl Med 1997; 38:636-643.
10. Henry TR, Mazziotta JC, Engel J Jr., et al. Quantifying interictal metabolic activity in human temporal lobe epilepsy. J Cer Blood Flow Metab 1990;10:748-757.
11. Di Chiro G, DeLaPaz RL, Brooks RA, et al. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 1982;32:1323-1329.